CYP17A1 and Insulin resistance: This suggests that deletion of the Cyp17a1 gene may suppress insulin resistance, but further research involving a comprehensive analysis of glucose-lipid metabolism including skeletal muscle and liver [40–42] is necessary to confirm the effectiveness of the Cyp17a1 KO model.